Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome-Reference-Cited by-同舟云学术

Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome

Published:2015-09 Issue:1 Volume:28 Page:390-398
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Li Hong-tao,Zhang Tian-tuo,Chen Zhuang-gui,Ye Jin,Liu Hui,Zou Xiao-ling,Wang Yan-hong,Yang Hai-ling

Funder

Guangdong Natural Science Foundation

Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference47 articles.

1. The connection between allergic rhinitis and bronchial asthma;Corren;Curr. Opin. Pulm. Med.,2007

2. Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome;Wen;Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,2011

3. United airways: circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation;KleinJan;Clin. Exp. Allergy,2010

4. Allergic rhinitis is associated with poor asthma control in children with asthma;de Groot;Thorax,2012

5. Airway hyperresponsiveness: a comparative study of methacholine and exercise challenges in seasonal allergic rhinitis with or without asthma;BlA;J. Asthma,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morita-Baylis-Hillman adduct 2-(3-hydroxy-1-methyl-2-oxoindolin-3-il) acrylonitrile (CISACN) ameliorates the pulmonary allergic inflammation in CARAS model by increasing IFN-γ/IL-4 ratio towards the Th1 immune response;International Immunopharmacology;2024-03

2. The Use of Chitosan Nanoparticles for Delivery of CpG ODN in Treatment of Allergic Balb/C Mice;Reports of Biochemistry and Molecular Biology;2023-02-01

3. Recent advances in improving intranasal allergen-specific immunotherapy; focus on delivery systems and adjuvants;International Immunopharmacology;2022-12

4. CCR3 gene knockout in bone marrow cells ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing airway inflammatory cell infiltration and Th2 cytokines expression in mice model;International Immunopharmacology;2022-03

5. Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy;Frontiers in Immunology;2020-11-12